STOCK TITAN

Ludwig Enterprises Inc - LUDG STOCK NEWS

Welcome to our dedicated news page for Ludwig Enterprises (Ticker: LUDG), a resource for investors and traders seeking the latest updates and insights on Ludwig Enterprises.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ludwig Enterprises's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ludwig Enterprises's position in the market.

Rhea-AI Summary
Ludwig Enterprises, Inc. announces funding for a preclinical study on Glioblastoma, an incurable brain cancer, showing promising results in enhancing traditional cancer therapies by 400%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.5%
Tags
none
-
Rhea-AI Summary
Ludwig Enterprises, Inc. partners with Dr. Kyle Ambert from Nike Inc. to develop a groundbreaking cancer diagnostic test using AI technology. The company's mRNA for Life™ test aims to detect cancer early through noninvasive buccal cell analysis, potentially tapping into the billion-dollar cancer screening market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Ludwig Enterprises, Inc. (LUDG) announces a breakthrough in cancer screening with the successful filing of a patent for identifying mRNA genes associated with colorectal, breast, and bladder cancer. The company's mRNA for Life™ test is a noninvasive at-home screening test that could revolutionize cancer diagnostics, positioning Ludwig to enter the billion-dollar diagnostic cancer screening market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.7%
Tags
none
Rhea-AI Summary
Ludwig Enterprises, Inc. has received Continuing Review Approval from Advarra IRB for its planned clinical study, LL301, focused on evaluating pre- and post-diagnosis and treatment response of patients with Urothelial Carcinoma of the Bladder. The study also includes potential breakthrough genetic results in BCG treatment of bladder cancer, covered in a filed international patent application. CEO Marvin S. Hausman MD expressed excitement for the study's launch and the creation of a personalized patient genetic index to evaluate patient response to BCG immunotherapy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.37%
Tags
none
-
Rhea-AI Summary
Ludwig Enterprises, Inc (OTC:LUDG) announces subsidiary Exousia AI's contract with Eternapure LLC for Liposome delivery system research and development. The company aims to develop cargo delivery platforms containing genetic mRNA and DNA, and nutritional compounds. CEO Marvin S. Hausman MD expresses positivity for the research program, with plans for additional similar arrangements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary
Ludwig Enterprises, Inc. (LEI) Announces Appointment of Scott Silverman as Chief Financial Officer (CFO)
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary
Ludwig Enterprises, Inc. (LUDG) - SEC Declares Registration Statement Effective, Seeking to Raise $23.5M through Common Stock Offering
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.36%
Tags
none
-
Rhea-AI Summary
Marvin S. Hausman MD joins Ludwig Enterprises as CEO, expressing excitement about the potential of their mRNA technology to save lives and lower healthcare budgets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.49%
Tags
none
Ludwig Enterprises Inc

OTC:LUDG

LUDG Rankings

LUDG Stock Data

90.60M
81.07M
47.17%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States
Sparks